These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

104 related articles for article (PubMed ID: 19720639)

  • 1. The quest for a 'better mousetrap'.
    Kugelmass AD
    Eur Heart J; 2009 Oct; 30(20):2431-2. PubMed ID: 19720639
    [No Abstract]   [Full Text] [Related]  

  • 2. HOTLINE II, ISAR-TEST-4 trial, biodegradable stent coatings show promise.
    Eur Heart J; 2009 Nov; 30(21):2543. PubMed ID: 19891081
    [No Abstract]   [Full Text] [Related]  

  • 3. Drug-eluting stents: effective and safe for every patient and every lesion?
    Zeymer U; Zahn R
    Eur Heart J; 2007 Nov; 28(21):2559-60. PubMed ID: 17938127
    [No Abstract]   [Full Text] [Related]  

  • 4. Drug-eluting stents: limitations of early generation and progress with newer generation devices.
    Khattab AA; Windecker S
    Minerva Med; 2010 Feb; 101(1):9-23. PubMed ID: 20228717
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Coronary stents: looking forward.
    Garg S; Serruys PW
    J Am Coll Cardiol; 2010 Aug; 56(10 Suppl):S43-78. PubMed ID: 20797503
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Drug-eluting coronary stents: many meta-analyses, little benefit.
    Prescrire Int; 2009 Apr; 18(100):70-4. PubMed ID: 19585727
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Could Paclitaxel-eluting stents be superior to sirolimus-eluting stents for the treatment of saphenous vein graft lesions?
    Brilakis ES; Banerjee S
    Am J Cardiol; 2010 Nov; 106(9):1367-8. PubMed ID: 21029842
    [No Abstract]   [Full Text] [Related]  

  • 8. Critical role of bare-metal stent controls in trials of drug-eluting stents.
    Biondi-Zoccai GG; Agostoni P; Abbate A; Airoldi F; Colombo A
    Eur Heart J; 2005 Aug; 26(16):1686-7; author reply 1687. PubMed ID: 15946954
    [No Abstract]   [Full Text] [Related]  

  • 9. Optimal treatment for in-stent restenosis after BMS--DES, coated balloon, or scalpel?
    Mukherjee D
    Eur Heart J; 2008 Jul; 29(13):1595-6. PubMed ID: 18556717
    [No Abstract]   [Full Text] [Related]  

  • 10. Directional coronary atherectomy and implantation of drug-eluting stents in selected bifurcation lesions: a logical combination waiting evidence.
    Colombo A
    J Am Coll Cardiol; 2007 Nov; 50(20):1946-7. PubMed ID: 17996558
    [No Abstract]   [Full Text] [Related]  

  • 11. Drug-eluting stents: from randomized trials to the real world.
    Saia F; Degertekin M; Lemos PA; Serruys PW
    Minerva Cardioangiol; 2004 Oct; 52(5):349-63. PubMed ID: 15514571
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Biodegradable polymer-coated - new step in coronary arteriosclerosis intervention].
    Siminiak T
    Kardiol Pol; 2010 May; 68(5):510-1. PubMed ID: 20491009
    [No Abstract]   [Full Text] [Related]  

  • 13. Coronary artery restenosis: a paradigm of current treatment approaches.
    Kiernan TJ; Kiernan GD; Yan BD
    Minerva Cardioangiol; 2009 Feb; 57(1):77-94. PubMed ID: 19202520
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Robustness of late lumen loss in discriminating drug-eluting stents across variable observational and randomized trials.
    Mauri L; Orav EJ; Candia SC; Cutlip DE; Kuntz RE
    Circulation; 2005 Nov; 112(18):2833-9. PubMed ID: 16267256
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Cochrane reviews. Are coated stents really more effective?].
    Pittler MH; Antes G
    Dtsch Med Wochenschr; 2010 Nov; 135(45):2229. PubMed ID: 21046528
    [No Abstract]   [Full Text] [Related]  

  • 16. [Drug-eluting stents for diabetic patients. A critical appraisal of the currently available data from randomized trials].
    Silber S; Herdeg C
    Herz; 2008 Apr; 33(3):196-205. PubMed ID: 18568314
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Randomized, non-inferiority trial of three limus agent-eluting stents with different polymer coatings: the Intracoronary Stenting and Angiographic Results: Test Efficacy of 3 Limus-Eluting Stents (ISAR-TEST-4) Trial.
    Byrne RA; Kastrati A; Kufner S; Massberg S; Birkmeier KA; Laugwitz KL; Schulz S; Pache J; Fusaro M; Seyfarth M; Schömig A; Mehilli J;
    Eur Heart J; 2009 Oct; 30(20):2441-9. PubMed ID: 19720642
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Efficacy and safety of drug-eluting stents: current best available evidence.
    Raja SG; Dreyfus GD
    J Card Surg; 2006; 21(6):605-12; discussion 613-4. PubMed ID: 17073969
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Surrogates, substudies, and real clinical end points in trials of drug-eluting stents.
    Kereiakes DJ; Kuntz RE; Mauri L; Krucoff MW
    J Am Coll Cardiol; 2005 Apr; 45(8):1206-12. PubMed ID: 15837250
    [No Abstract]   [Full Text] [Related]  

  • 20. [Drug-eluting stents in multivessel coronary artery disease: Was one of the important fortresses of surgery conquered?].
    Okmen AS; Okmen E
    Anadolu Kardiyol Derg; 2009 Aug; 9(4):325-30. PubMed ID: 19666436
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.